• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
6,124 results

Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.

Docket 23-1977, U.S. Court of Appeals, Federal Circuit (June 5, 2023)
Patent - Abbreviated New Drug Application (ANDA)
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
Plaintiff - Appellant AZURITY PHARMACEUTICALS, INC.
Defendant - Appellee ALKEM LABORATORIES LTD.
cite Cite Docket
Analyze

Celgene Corporation v. Hetero Labs Limited

Docket 21-2335, U.S. Court of Appeals, Federal Circuit (Sept. 21, 2021)
Patent
Case Type830 Patent
Tags830 Patent, 830 Patent
Plaintiff - Appellant CELGENE CORPORATION
Defendant HETERO LABS LIMITED
Defendant HETERO LABS LIMITED UNIT-V
...
cite Cite Docket
Analyze

Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.

Docket 1:23-cv-01015, Delaware District Court (Sept. 15, 2023)
Judge William C. Bryson, presiding
Patent - Abbreviated New Drug Application (ANDA)
DivisionWilmington
FlagsPATENT
Cause35:271 Patent Infringement
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
DeadlineIT IS HEREBY STIPULATED AND AGREED, by the parties, subject to the approval of the Court, that the following deadlines shall be modified as follows to accommodate the availability of the parties’ fact witnesses and to adjust the deadline for Case Dispositive Motions and Daubert Motions to the same deadline because the Scheduling Order requires them to be briefed together (D.I. 38 at ¶ 14): Event Currently Noticed Depositions Opening Expert Reports Responsive Expert Reports Reply Expert Reports Close of Expert Discovery Case Dispositive Motions Daubert Motions Trial Current Deadline N/A October 28, 2024 December 2, 2024 January 6, 2025 February 10, 2025 February 24, 2025 February 27, 2025 May 19, 2025 Stipulated Proposal October 22, 2024 November 15, 2024 December 20, 2024 January 17, 2025 February 21, 2025 February 28, 2025 February 28, 2025 May 19, 2025 (unchanged) No other deadlines in the Scheduling Order shall be affected by this stipulation., A 5 Day Bench Trial is set for 5/19/2025 - 5/23/2025 at 08:30 AM in To Be Determined before Judge William C. Bryson.
DeadlineA 5 Day Bench Trial is set for 5/19/2025 - 5/23/2025 at 08:30 AM in To Be Determined before Judge William C. Bryson.
Plaintiff Heron Therapeutics, Inc.
Defendant Mylan Pharmaceuticals Inc.
Counter Claimant Mylan Pharmaceuticals Inc.
...
cite Cite Docket
Analyze

Sanofi-Aventis U.S. LLC v. Mylan GmbH

Docket 21-1262, U.S. Court of Appeals, Federal Circuit (Nov. 19, 2020)
Patent - Abbreviated New Drug Application (ANDA)
08/03/2021
... Appellees Biocon Ltd., Biocon Research Ltd., Biocon S.A., Biocon Sdn.Bhd and Mylan GmbH regarding conflicts with oral argument. None. Service: 08/03/2021 by email. [790319] [21-1262] [...
cite Cite Docket
Analyze

Celgene Corporation v. Mylan Pharmaceuticals Inc.

Docket 21-1154, U.S. Court of Appeals, Federal Circuit (Nov. 5, 2020)
Patent - Abbreviated New Drug Application (ANDA)

cite Cite Docket
Analyze

Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al

Docket 1:23-cv-00556, Delaware District Court (May 19, 2023)
Judge Richard G. Andrews, presiding.
Patent - Abbreviated New Drug Application (ANDA)

cite Cite Docket
Analyze

Sanofi-Aventis Deutschland v. Mylan Pharmaceuticals, Inc.

Docket 20-2071, U.S. Court of Appeals, Federal Circuit (July 27, 2020)

cite Cite Docket
Analyze

Sanofi-Aventis Deutschland v. Mylan Pharmaceuticals Inc.

Docket 20-2066, U.S. Court of Appeals, Federal Circuit (July 27, 2020)

cite Cite Docket
Analyze
1 2 3 4 5 ... >>